ProMIS Neurosciences, Inc. (PMN)
10.85
+0.25
(+2.36%)
USD |
NASDAQ |
May 21, 16:00
10.74
-0.11
(-1.01%)
After-Hours: 19:59
ProMIS Neurosciences Research and Development Expense (TTM) : 34.89M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 34.23M |
| Edesa Biotech, Inc. | 6.056M |
| Xenon Pharmaceuticals, Inc. | 325.78M |
| Medicus Pharma Ltd. | 6.093M |
| Achieve Life Sciences, Inc. | 19.19M |